Michael Scherer1, Paul Harrell2, Eduardo Romano1. 1. Pacific Institute for Research and Evaluation, Calverton, Maryland. 2. Eastern Virginia Medical School, Norfolk, Virginia.
Abstract
OBJECTIVE: The deleterious effect of multiple-substance use on driving performance is well established, but relatively little research has examined the patterns of drug use among multiple-substance users and its relationship to both alcohol use and adverse driving outcomes. METHOD: The current study used latent class analysis to examine subgroups of substance users among a population of drivers who screened positively for 2 or more of 13 substances other than alcohol (N = 250). A series of logistic regression analyses was conducted to examine demographic predictors of latent class assignment and class association with adverse driving outcomes. RESULTS: Four distinct subclasses of users were identified among multiple-substance-using drivers: Class 1 consisted of individuals who demonstrated high levels of all substances indicators (5%). The second class demonstrated high levels of marijuana and cocaine use and lower levels of all other substances (27%). The third class screened high for marijuana and nonmedical prescription opiate analgesics use (36%), whereas the last class demonstrated high nonmedical prescription opiate analgesics and benzodiazepine use (32%). Drivers in Class 2 (marijuana and cocaine users) were more likely to be younger and have a positive breath alcohol concentration than drivers in any other class. CONCLUSIONS: Because multidrug users show dissimilar characteristics, the propensity of researchers to lump all multiple-substance users together may either erroneously attribute the potentially profound impact of those in the marijuana and cocaine use class to all multiple-substance users or dilute their specific contribution to crash risk.
OBJECTIVE: The deleterious effect of multiple-substance use on driving performance is well established, but relatively little research has examined the patterns of drug use among multiple-substance users and its relationship to both alcohol use and adverse driving outcomes. METHOD: The current study used latent class analysis to examine subgroups of substance users among a population of drivers who screened positively for 2 or more of 13 substances other than alcohol (N = 250). A series of logistic regression analyses was conducted to examine demographic predictors of latent class assignment and class association with adverse driving outcomes. RESULTS: Four distinct subclasses of users were identified among multiple-substance-using drivers: Class 1 consisted of individuals who demonstrated high levels of all substances indicators (5%). The second class demonstrated high levels of marijuana and cocaine use and lower levels of all other substances (27%). The third class screened high for marijuana and nonmedical prescription opiate analgesics use (36%), whereas the last class demonstrated high nonmedical prescription opiate analgesics and benzodiazepine use (32%). Drivers in Class 2 (marijuana and cocaine users) were more likely to be younger and have a positive breathalcohol concentration than drivers in any other class. CONCLUSIONS: Because multidrug users show dissimilar characteristics, the propensity of researchers to lump all multiple-substance users together may either erroneously attribute the potentially profound impact of those in the marijuana and cocaine use class to all multiple-substance users or dilute their specific contribution to crash risk.
Authors: Frederick S Stinson; Bridget F Grant; Deborah A Dawson; W June Ruan; Boji Huang; Tulshi Saha Journal: Drug Alcohol Depend Date: 2005-04-18 Impact factor: 4.492
Authors: Stephen T Higgins; Sarah H Heil; Robert Dantona; Robert Donham; Martha Matthews; Gary J Badger Journal: Addiction Date: 2007-02 Impact factor: 6.526
Authors: Nicole T Flowers; Timothy S Naimi; Robert D Brewer; Randy W Elder; Ruth A Shults; Ruth Jiles Journal: Alcohol Clin Exp Res Date: 2008-03-13 Impact factor: 3.455
Authors: Lorenzo Zamboni; Igor Portoghese; Alessio Congiu; Thomas Zandonai; Rebecca Casari; Francesca Fusina; Anna Bertoldi; Fabio Lugoboni Journal: Front Psychiatry Date: 2022-01-25 Impact factor: 4.157